Cited by 321Blood properties and coagulationBlood Coagulation and Thrombosis MechanismsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors

FOLSOM, A, WU, K, DAVIS, C, CONLAN, M, SORLIE, P, SZKLO, M·1991·Atherosclerosis

DOI 10.1016/0021-9150(91)90167-2

Open this paper in CoChat — free account

Abstract

Recent prospective investigations have reported that higher plasma fibrinogen concentrations and higher factor VII coagulant activity are associated with greater risk of cardiovascular disease. To discover what characteristics may influence fibrinogen and factor VII, we analyzed data from the Atherosclerosis Risk in Communities Study obtained from over 12,000 men and women, aged 45-64 years, from four communities in December 1986 to June 1989. Fibrinogen was higher in blacks than whites and in women than men; in general, it increased with age, smoking, body size, diabetes, fasting serum insulin, LDL cholesterol, lipoprotein(a), leukocyte count, and menopause, and it decreased with ethanol intake, physical activity, HDL cholesterol, and female hormone use. Factor VII was higher in women than men and, in women, increased with age; in both sexes, it increased with body size, triglycerides, LDL cholesterol, and HDL cholesterol, and it decreased with ethanol intake. These findings indicate that elevations in fibrinogen and factor VII may be modifiable through appropriate lifestyle changes.

Integrity signals

Registry

Crossref · 10.1016/0021-9150(91)90167-2

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J. A. H., BUREMA, J., & Frijters, J. E. R. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,950
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (2009) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,239
Untitled work
(1989) · PubMed · Cited by 3,139
Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,154
HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY
Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,645
Fibrinogen and risk of cardiovascular disease. The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.258.9.1183 · Cited by 1,387
Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency.
Siedel, J., Hägele, E., Ziegenhorn, J., & Wahlefeld, A. W. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.6.1075 · Cited by 942
Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.
YARNELL, J. W. G., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., WHITEHEAD, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 915

Show all 52 references

Sorted by citations

Items 201–300 of 321

Distribution and Cardiovascular Risk Correlates of Serum Triglycerides in Young Japanese Adults.
Nakanishi, N., OKAMOTA, M., Makino, K., SUZUKI, K. S., & Tatara, K. (2002) · Industrial Health · doi:10.2486/indhealth.40.28 · Cited by 15
Serum phospholipids are the main environmental determinants of activated factor VII in the most common FVII genotype. European Union Concerted Action "Clotart".
Mariani, G., Bernardi, F., Bertina, R. M., Vicente, V., Prydz, H., Samama, M. M., Sandset, P., Nucci, G. D., Testa, M. G., Bendz, B., et al. (1999) · PubMed · Cited by 16
9 The menopause and the cardiovascular system
Beale, C. M., & Collins, P. (1996) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(96)80027-7 · Cited by 16
Effect of gemfibrozil treatment on fibrinolysis system in patients with hypertriglyceridemia
Avellone, G., Garbo, V. D., Cordova, R., Raneli, G., Simone, R. D., & Bompiani, G. (1992) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80485-0 · Cited by 16
Small dense LDL: risk factor for coronary artery disease (CAD) and its therapeutic modulation.
Sharma, S. B., & Garg, S. (2012) · PubMed · Cited by 15
Influence of factor VII gene polymorphisms and environmental factors on plasma coagulation factor VII concentrations in middleaged women with and without manifest coronary heart disease
Eriksson-Berg, M., Deguchi, H., Hawe, E., Scanavini, D., Orth‐Gomér, K., Schenck-Gustafsson, K. G., Humphries, S. E., Silveira, A. M. V., & Hamsten, A. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-09-0616 · Cited by 15
Dietary fatty acids and blood coagulation
Miller, G. J. (1997) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(97)90416-6 · Cited by 15
Factor VII coagulant activity, factor VII −670A/C and −402G/A polymorphisms, and risk of venous thromboembolism
Folsom, A. R., Cushman, M., Heckbert, S. R., Ohira, T., Rasmussen‐Torvik, L. J., & Tsai, M. Y. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02620.x · Cited by 15
Self-citation
Effects of estradiol on myocardial global performance index in hypertensive postmenopausal women
Aldrighi, J. M., Alecrin, I., Caldas, M. A., Gebara, O., Ramires, J. A. F., & Rosano, G. M. C. (2004) · Gynecological Endocrinology · doi:10.1080/09513590400017464 · Cited by 15
“001 LH (mUI/ml) baseline (T1) 20 (9) 25 (10) ns 90 min (T2) 20 (7) 24 (10) ns 12 weeks (T3) 12 (7) 25 (10) 5 0.”
Hemostatic tests in the prediction of atherothrombotic disease
Wu, K. K. (1997) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02912450 · Cited by 15
Self-citation
Plasma phospholipid fatty acid composition and factor VII coagulant activity
Folsom, A. R., Ma, J., Eckfeldt, J. H., Shahar, E., & Wu, K. K. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90094-9 · Cited by 15
Self-citation
Relative Influence of Age and Thrombotic History on Hemostatic Parameters
Javorschi, S., Richard‐Harston, S., Labrouche, S., Manciet, G., & Freyburger, G. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00104-2 · Cited by 14
Effects of coagulation Factor VII polymorphisms on the coronary artery disease in Japanese
Shimokata, K., Kondo, T., Ohno, M., Takeshita, K., Inden, Y., Iino, S., Saito, H., & Hirai, M. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00067-1 · Cited by 14
“Second, FVIIc is related to age, lipid level and obesity [9–11].”
Background
Haemostasis and carotid artery wall thickness in non-insulin dependent diabetes mellitus
Metcalf, P., Folsom, A. R., DAVIS, C. E., Wu, K. K., & HEISS, G. M. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00092-3 · Cited by 14
Self-citation
Elevated plasma factor VIII and von Willebrand factor in women with type 2 diabetes
Soares, A. L., Kazmi, R. S., Borges, M. A. R., Rosário, P. W., Fernandes, A. P., Sousa, M. O., Lwaleed, B. A., & Ferriani, M. D. G. C. (2011) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32834b2fe1 · Cited by 13
Smoking and lipoprotein abnormalities on platelet aggregation in coronary heart disease
Mansur, A. D. P., Caramelli, B., Vianna, C. B., Chamone, D. A. F., & Ramires, J. A. F. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(97)00203-9 · Cited by 13
Le fibrinogène a-t-il une place pour évaluer le risque d’accident cardiovasculaire ischémique ?
Drouet, L. O., & Sollier, C. B. D. (2005) · Therapies · doi:10.2515/therapie:2005017 · Cited by 12
Does body mass index, smoking, lipoprotein levels, surgically induced menopause, hormone replacement therapy, years since menopause, or age affect hemostasis in postmenopausal women?
Pripp, U., Eriksson-Berg, M., Orth‐Gomér, K., Schenck-Gustafsson, K. G., & Landgren, B.-M. (2005) · Gender Medicine · doi:10.1016/s1550-8579(05)80015-4 · Cited by 12
The effects of long-term regular exercise on endothelial functions, inflammatory and thrombotic activity in middle-aged, healthy men.
Ergün, M., Tengiz, İ., Türk, U. Ö., Şenışık, S., Alioğlu, E., Yüksel, O., Ercan, E., & İşleğen, Ç. (2006) · Europe PMC (PubMed Central) · Cited by 12
Thrombogenic Risk Factors for Cardiovascular Disease in Dialysis Patients
Culleton, B. F., & Wilson, P. W. F. (1999) · Seminars in Dialysis · doi:10.1046/j.1525-139x.1999.00002.x · Cited by 12
Physical activity, fitness, and plasma fibrinogen with reference to fibrinogen genotypes
V??IS??NEN, S., Rauramaa, R., Rankinen, T., Gagnon, J., & Bouchard, C. (1996) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199609000-00013 · Cited by 12
Selected genetic polymorphisms and plasma coagulation factor VII changes with exercise training
Ghiu, I. A., Ferrell, R. E., Kulaputana, O., Phares, D. A., & Hagberg, J. M. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00877.2003 · Cited by 12
A Case-Reference Study on Plasma Fibrinogen Concentrations and Coronary Atherosclerosis in Japanese
Sato, S., Kobayashi, T., Iida, M., Naito, Y., Kiyama, M., Kitamura, A., Iso, H., & Komachi, Y. (1996) · Journal of Epidemiology · doi:10.2188/jea.6.81 · Cited by 12
Plasma fibrinogen level is not elevated in young adults from families with premature ischemic heart disease.
Hoffman, C. J., Burns, P. A. C., Lawson, W. E., Katz, J., Miller, R. H., & Hultin, M. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.800 · Cited by 11
Interrelationships of factor VII activity and plasma leptin with insulin resistance in coronary heart disease
Karatela, R. A., & Sainani, G. S. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.043 · Cited by 11
Fibrinogen levels in women having coronary angiography
Eichner, J. E., Moore, W. E., McKee, P. A., Schlechter, E., REYNOLDS, D. W., Qi, H., & Comp, P. C. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00219-6 · Cited by 11
Plasma Level of Triglyceride-rich Lipoprotein Remnants Is Closely Associated with the Activation of Coagulation Factor VII in Patients with Myocardial Infarction
Saigo, M., Abe, S., Ogawa, M., Biro, S., Minagoe, S., Maruyama, I., Toda, H., Kiyonaga, K., Atsuchi, Y., Tahara, M., et al. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00290-5 · Cited by 11
Prolonged very low calorie diet in obese subjects reduces factor VII and PAI but not fibrinogen levels
Palareti, G., Legnani, C., Poggi, M., PARENTI, M. A., Babini, A. C., Biagi, R., Baraldi, L., Luchi, A., Capelli, M., & COCCHERI, S. (1994) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(94)90027-2 · Cited by 11
The relationship between cardiometabolic and hemostatic variables: influence of race
PERRY, A. C., Wang, X., Goldberg, R., Ross, R., & Jackson, L. (2008) · Metabolism · doi:10.1016/j.metabol.2007.09.001 · Cited by 10
“Black adults have been reported to have higher fibrinogen levels [11], yet few studies have examined CMV in relation to various indices of hemostasis in both White American (WA) and African American (AA) women.”
Background
Cardiovascular Pathophysiology
Derby, C. A. (2000) · Elsevier eBooks · doi:10.1016/b978-012453790-3/50016-0 · Cited by 10
Sex-related differences in outcomes after vascular interventions
Brinza, E., & Armstrong, E. J. (2018) · Vascular Medicine · doi:10.1177/1358863x18790105 · Cited by 5
Fibrinogen, fibrin turnover, endothelial products and vascular surgery
Woodburn, K. R., & Lowe, G. D. O. (1997) · British journal of surgery · doi:10.1002/bjs.1800840806 · Cited by 10
Leisure time physical activity, cardiorespiratory fitness, and plasma fibrinogen concentrations in nonsmoking middle-aged men
Carroll, S., Cooke, C. B., & Butterly, R. J. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200003000-00011 · Cited by 10
Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. Medical Research Council's General Practice Research Framework.
(1996) · PubMed Central · Cited by 10
Plasma Coagulation Factors
Sakkinen, P. A., & Tracy, R. P. (2008) · Springer eBooks · doi:10.1007/978-0-585-33754-8_2 · Cited by 10
Increased thrombin generation and complement activation in patients with type IIA hyperlipoproteinemia: effects of simvastatin treatment
Garbo, V. D., Cordova, R., & Avellone, G. (1997) · Current Therapeutic Research · doi:10.1016/s0011-393x(97)80105-1 · Cited by 10
Determinants of Cardiovascular Risk in Diabetes Beyond Hyperglycemia
Badimón, L., Vera, R. H., & Vilahur, G. (2013) · Cited by 9
Lipoprotein(a) and its correlates in Japanese and U.S. population samples
Iso, H., KOIKE, K. A., Folsom, A. R., Shimamoto, T., Sato, S., lida, M., & Komachi, Y. (1996) · Annals of Epidemiology · doi:10.1016/s1047-2797(96)00050-6 · Cited by 9
Self-citation
Identification of genetic variation that determines levels of plasma triglycerides and hypercoagulability
Humphries, S. E., Peacock, R. E., Dunning, A. M., Lane, A. M., Green, F. R., & Hamsten, A. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb04198.x · Cited by 9
Haemostasis in Relation to Dietary Fat as Estimated by Erythrocyte Fatty Acid Composition: The Prime Study
Scarabin, P., Aillaud, M. F., Luc, G., Lacroix, B., Mennen, L. I., Amouyel, P., Evans, A., Ferrières, J., Arveiler, D., & Juhan-Vague, I. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(01)00245-6 · Cited by 9
Glycated Hemoglobin Levels and Their Correlation With Atherosclerotic Risk Factors in a Japanese Population
Kayaba, K., Nago, N., Miyamoto, T. K., Mizooka, M., Terada, M., Kario, K., Nakamura, Y., & lgarashi, M. (1998) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.62.261 · Cited by 9
Psychosocial job characteristics and plasma fibrinogen in Japanese male and female workers: the Jichi Medical School cohort study
Hirokawa, K., Tsutsumi, A., & Kayaba, K. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.035 · Cited by 8
Lipoprotein (a): A link between thrombogenesis and atherogenesis
Vučković, B., & Djerić, M. (2007) · Medicinski pregled · doi:10.2298/mpns0702037v · Cited by 8
Effects of heparin treatment on hemostatic abnormalities in obese non—insulin-dependent diabetic patients
Avellone, G., Garbo, V. D., Cordova, R., Rotolo, G., Raneli, G., Simone, R. D., & Bompiani, G. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90082-2 · Cited by 8
Exercise and Haemostatic Function
Meade, T. W. (1995) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679500200407 · Cited by 8
Utility of the Arg/Gln polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FVII:C and FVII:Ag in North Karelia; a cross-sectional and prospective study
Stengård, J., Salomaa, V. V., Rasi, V., Vahtera, E. M., Ehnholm, C., Krusius, T., Perola, M., & Vartiainen, E. A. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200109000-00004 · Cited by 8
“At least in women, these levels have been demonstrated to increase with advancing age [10] and to decrease in individuals who have reduced their fat consumption [26,27].”
Background
Individuals with coronary artery disease at a young age and features of the metabolic syndrome have an increased prothrombotic potential
Kok, M. G. M., Meijers, J. C. M., & Pinto‐Sietsma, S. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0587 · Cited by 7
“Epidemiological data suggests an association between fibrinogen levels and increasing body mass index (27, 28) as well as reduced HDL-cholesterol levels (27).”
Background
Relationship between plasma fibrinogen and fiber intake in the EPIC-Norfolk cohort
de Freitas, R. N., Luben, R., Wareham, N. J., & Khaw, K. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.194 · Cited by 7
“The effect of BMI and alcohol intake on plasma fibrinogen, for example, may be larger in women (Folsom et al., 1991).”
Background
Venous thromboembolism: racial and ethnic influences
Patel, R., & Arya, R. (2008) · Therapy · doi:10.2217/14750708.5.2.169 · Cited by 7
“Fibrinogen levels are reported to be higher in African–American populations than in US whites [64,65], and have been weakly associated with VTE in this group [66].”
Background
Changes in the complete blood count and blood rheology in patients after myocardial infarction participating in the rehabilitation programme
Pabisiak, A. M., Bromboszcz, J., Kmieć, S., Dendura, M., Dąbrowski, Z., & Smoleński, O. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-151954 · Cited by 7
Cardiovascular Diseases
Peek, S. F. (2008) · Elsevier eBooks · doi:10.1016/b978-141603137-6.50006-5 · Cited by 7
Smoking status and antithrombin therapy in patients with non–ST-segment elevation acute coronary syndrome
Leung, S., Gallup, D. S., Mahaffey, K. W., Cohen, M. C., Antman, E. M., Goodman, S. G., Harrington, R. A., Langer, A., Aylward, P. E., Ferguson, J. J., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.02.002 · Cited by 7
Fibrinogen and other coronary risk factors
von Eyben, F. E., Mouritsen, E., Holm, J., Montvilas, P., Dimcevski, G., Rasmussen, I. H., Kristensen, L. L., Suciu, G., & von Eyben, R. (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.008 · Cited by 7
“Several other coronary risk factors are associated with plasma fibrinogen concentration [4-13], for example, age, social class, physical fitness, smoking, obesity measured as body mass index, abdominal obesity measured as waistto-hip ratio, serum concentrations of total cholesterol, highdensity lipoprotein (HDL) chole…”
Background
Triglyceride concentration and waist circumference influence alcohol-related plasminogen activator inhibitor-1 activity increase in black South Africans
Pieters, M., de Lange, Z., Hoekstra, T., Ellis, S. M., & Kruger, A. (2010) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32834014e2 · Cited by 7
Influences of lipid and non‐lipid nutritional parameters on factor VII coagulant activity in normal subjects: the Nove Study
Girelli, D., Olivieri, O., Arigliano, P. L., Guarini, P., Bassi, A., & Corrocher, R. (1996) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1996.117265.x · Cited by 7
Fibrin(ogen) and diabetes mellitus: don't forget fibrinolysis
Morale, M., Negri, F. D., & Carmassi, F. (1997) · Diabetologia · doi:10.1007/s001250050742 · Cited by 7
“In the inflammatory state fibrinogen increases with peripheral leukocyte count [ 1 ].”
Background
Putting prevention into daily practice
Steinhoff, J. P., & Smith, S. C. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00077-8 · Cited by 6
Assays for thrombosis factors: relations to plasma lipids
Tracy, R. P. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1669s · Cited by 6
Fibrinogen
de Maat, M. P. M., Lowe, G. D. O., & Haverkate, F. (1999) · Springer eBooks · doi:10.1007/978-94-011-4722-4_8 · Cited by 6
The Decanucleotide Polymorphism in the Factor VII Promoter Predicts Factor VII Plasma Levels but not the Risk of Acute Coronary Syndromes
Jimenez-Boj, E., Schüttrumpf, J., Forberg, E., Watzke, H., & Huber, K. (2000) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1018790519492 · Cited by 6
Genotype-specific increase in plasma concentrations of activated coagulation factor VII in response to experimental inflammation
Held, C., Ericsson, C.-G., Silveira, A. M. V., Hamsten, A., Tornvall, P., & Bennermo, M. B. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0811 · Cited by 6
“Furthermore, age, body-mass-index, oral contraceptive use, menopausal status and hormone replacement therapy are associated with variation of mass and activity of FVII (11, 12).”
Background
Cord blood clotting factors in neonates of smoking and non-smoking mothers
van der Salm, P. C., Ubachs, H. M. H., & van Wersch, J. W. J. (1994) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02592450 · Cited by 6
The effect of moderate alcohol ingestion on blood coagulation and fibrinolysis at rest and in response to exercise
Elsayed, M., Eastland, P., LIN, X., & Rattu, A. J. M. (1999) · Journal of Sports Sciences · doi:10.1080/026404199365821 · Cited by 6
Plasma levels of factor XIIa and factor VIIa are increased but not related in primary hyperlipidaemia
Cardigan, R. A., Crook, M. A., Mackie, I. J., & Machin, S. J. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200104000-00004 · Cited by 6
“The association of FVII:C activity [17] and FXIIa [18] with triglyceride concentration in healthy adults suggests that there may be a link between increased plasma lipids and activation of both FVII and FXII.”
Background
Responsiveness of ATIII and coagulation factors V and VII to a standardized oral fat load
Orth, M., Luley, C. H., Mayer, H., & Wieland, H. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00175-q · Cited by 6
Global REACH 2018: Influence of excessive erythrocytosis on coagulation and fibrinolytic factors in Andean highlanders
DeSouza, N. M., Brewster, L. M., Bain, A. R., Garcia, V. P., Stone, R. M., Stockelman, K. A., Greiner, J. J., Tymko, M. M., Vizcardo‐Galindo, G. A., Figueroa‐Mujíca, R., et al. (2021) · Experimental Physiology · doi:10.1113/ep089360 · Cited by 5
“For example, elevated factor VII levels have been shown to be associated with subclinical cardiovascular disease (Folsom et al., 1991; Junker et al., 1997), and factor VIII is predictive of ischaemic events in adultswithvascular disease (Cortellaroet al.”
Background
Physical Activity, Sedentary Behaviors, and Venous Thromboembolism: A Narrative Review of the Current Evidence
Kunutsor, S. K., & Laukkanen, J. A. (2024) · Heart and Mind · doi:10.4103/hm.hm-d-24-00034 · Cited by 5
Monthly intra-individual variation in lipoprotein(a) in 22 normal subjects over 12 months
Nazir, D. J., & McQueen, M. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(96)00163-4 · Cited by 5
Plasma fibrinogen and its correlates in adult Saudi population
Alam, A. A., Mitwalli, A., Al-Wakeel, J. S., Chaudhary, A. R., & Zebaid, M. A. (2004) · Saudi Medical Journal · doi:10.15537/1658-3175.2648 · Cited by 5
Hormone Therapy and Cardiovascular Disease
Chen, F. (2006) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(09)60245-x · Cited by 5
Idiopathic pulmonary thromboembolism in the course of intensive psychiatric inpatient care: case report and treatment guidelines
McInerney, S. J., & McDonald, C. (2012) · BMJ Case Reports · doi:10.1136/bcr.12.2011.5285 · Cited by 4
Sex-specific associations between serum lipids and hemostatic factors: the cross-sectional population-based KORA-fit study
von Falckenstein, J. V., Freuer, D., Peters, A., Heier, M., Teupser, D., Linseisen, J., & Meisinger, C. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01757-0 · Cited by 4
“In contrast, there was no notable association between LDL-c and AT III in the ARIC study [27].”
Result
Relationship of body mass index and waist-to-hip ratio with fibrinolytic activity measured as d-dimer
Franco, C. K., Silva, D. R., & Barreto, S. S. M. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2010.12.003 · Cited by 4
49. Hyperfibrinogenemia and cardiovascular risk: possible strategies for intervention
Köenig, W. (1996) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(96)80626-6 · Cited by 4
Beyond Coagulation: Fibrinogen as a Cause of Cardiovascular Surgical Disease
Sumeray, M. S., Montgomery, H., & Humphries, S. E. (1998) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007713715744 · Cited by 4
PUTTING PREVENTION INTO DAILY PRACTICE
Smith, S. C. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70218-2 · Cited by 4
Factor VII coagulant activity is related to blood lipids in the elderly. The Rotterdam study
van der Bom, J. G., Bots, M. L., van Vliet, H. H. D. M., Albert Hofman, D., & Grobbee, D. E. (1994) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(94)90274-7 · Cited by 4
Beverage Alcohol Consumption as a Negative Risk Factor for Coronary Heart Disease
Goldberg, D. M., & Soleas, G. J. (2001) · CRC Press eBooks · doi:10.3109/9780203902172-28 · Cited by 4
Correlation of Homocysteine Concentration with Plasma Fibrinogen and Physical Activity in Males with Coronary Artery Disease
Prerost, M. R. (1997) · VTechWorks (Virginia Tech) · Cited by 4
The Effects of Hormone Therapy on Inflammatory, Hemostatic, and Fibrinolytic Markers in Postmenopausal Women
Koh, K. K., Yoon, B.-K., Merz, C. N. B., Sakuma, I., & Rebar, R. W. (2007) · Elsevier eBooks · doi:10.1016/b978-012369443-0/50042-9 · Cited by 4
[Determination of blood markers and inflammation in subjects with impaired glucose tolerance].
Luciardi, H. L., Berman, S., Chaín, S., Feldman, G., Herrera, R. N., Muntaner, J. A., del Pino, E. J., Martínez-Réding, J., & Martínez-Sánchez, C. R. (2012) · PubMed · Cited by 4
Influence of stasis in fibrinogen values
Pola, P., Tondi, P., Martini, D. D., & Gerardino, L. (2005) · International Journal of Angiology · doi:10.1007/bf02014940 · Cited by 3
Decreased VLDL-Apo B 100 Fractional Synthesis Rate Despite Hypertriglyceridemia in Subjects With Type 2 Diabetes and Nephropathy
Tessari, P., Kiwanuka, E., Barazzoni, R., TOFFOLO, G. M., Vettore, M., Cortella, I., Manesso, E., Pasqualetto, G., Puricelli, L., Gabelli, C., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2172 · Cited by 3
Role of Fibrinogen as a Vascular Risk Factor in Atherogenesis and Thrombogenesis
Pola, P., Tondi, P., Serricchio, M., & Pola, R. (2000) · Springer eBooks · doi:10.1007/978-1-4612-1190-7_33 · Cited by 3
Oral contraceptives and oestrogen replacement therapy as determinants of plasma fibrinogen level and fibrinolytic activity the northern sweden MONICA study
Lundberg, V., Asplund, K., Evrin, P., & Eliasson, M. (1998) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(98)80389-5 · Cited by 3
Association of factor VII protein concentration with lifestyle factors
Bladbjerg, E., Møller, L. F., & Jespersen, J. (1998) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519850186508 · Cited by 3
The fibrinolytic enzyme system : New markers of potential interest in cardiovascular disease
Nordenhem, A. (2005) · Figshare · Cited by 3
Plasma Fibrinogen Levels and Their Association to Life Styles in the Rural Japanese Population
Kayaba, K., Nago, N., IGARASHI, M., Saegusa, T., Goto, T., Matsuo, H., KARIO, M., Tsutsumi, A., Ishikawa, S., MIYAMOTO, K., et al. (1995) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.6.477 · Cited by 3
Factor VII, antithrombin III, leukocyte and platelet counts in a sample of black and white Zimbabwean blood donors
Sigola, L. B., Mufunda, J., Adewuyi, J. O., & Keogh, E. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90141-4 · Cited by 2
Association of plasma fibrinogen and development of complications in type 2 diabetes mellitus
Patel, H. V., Sumple, R. S., Pooja Harshitha, K., & Sumple, K. R. (2023) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20231315 · Cited by 3
Hyperfibrinogenemia and cardiovascular risk: possible strategies for intervention
Köenig, W., Hoffmeister, A., & Hombach, V. (1997) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(97)80021-5 · Cited by 2
Fibrinogen, Factor VII, and Plasminogen Activator Inhibitor-1
Fay, W. P., & Ginsburg, D. (1994) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1130-0_9 · Cited by 2
Middle age is not associated with altered fibrinogen concentration and production in males
Tessari, P., Millioni, R., Vettore, M., Cecchet, D., & Puricelli, L. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0144-1 · Cited by 2
Fibrinolytic and Coagulation Factors in Very Old Subjects: Association With Lipoprotein Profile and Anthropometric Variables
Vergnani, L., Zuliani, G., Ricci, F., Manzoli, N., Carantoni, M., Volpato, S., & Fellin, R. (1998) · The Journals of Gerontology Series A · doi:10.1093/gerona/53a.1.m8 · Cited by 2
“Gender, glucose intolerance, obesity, and hyperlipemia are all conditions associated with elevated FVII levels and increased risk of death for ischemic heart diseases (11,12).”
Background
Hemostatic abnormalities associated with diabetes and their clinical implications
Kietsiriroje, N., Ajjan, R., & Grant, P. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00005-x · Cited by 1
Differences Between the Sexes in Cord Blood Clotting Factors
van der Salm, P. C., Ubachs, J. M. H., & van Wersch, J. W. J. (1994) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1994.32.4.301 · Cited by 1
“Moreover, oestrogen replacement therapy after onset of the menopause increases factor VII levels (12, 20).”
Background
Characteristics and Strategy of Cardiovascular Diseases in the Elderly
Sugiura, M., Sakai, M., Hayakawa, H., Doi, Y., Sugishita, Y., Kanmatsuse, K., & Naito, M. (1994) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.31.181 · Cited by 1
Pleiotropic effects of n-6 and n-3 fatty acid-related genetic variants on circulating hemostatic variables
Weng, L.-C. C., Guan, W., Steffen, L. M., Pankow, J. S., Pankratz, N., Chen, M., Cushman, M., Basu, S., Folsom, A. R., & Tang, W. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.05.032 · Cited by 1
Self-citation
factor mutant selectively deficient in promoting factor VII activation Quantitation of activated factor VII levels in plasma using a tissue
Morrissey, J. H., Macik, B., & Neuenschwander, P. (2011) · Cited by 1
Mapping Aging Biomarkers and Pathways Using Proteomics
Cui, T. (2022) · Academic Journal of Medicine & Health Sciences · doi:10.25236/ajmhs.2022.030209

Authors: FOLSOM, A., WU, K., DAVIS, C., CONLAN, M., SORLIE, P., & SZKLO, M.
Affiliations: University of Minnesota (US)
National Heart, Lung, and Blood Institute (US)
Johns Hopkins University (US)
Corresponding author: FOLSOM, A
ORCID: CONLAN, M
SZKLO, M
Venue: Atherosclerosis
Publisher: Elsevier BV
Published: 1991-12
Volume: 91
Issue: 3
Pages: 191-205
ISSN: 0021-9150 (ISSN-L)
DOI: 10.1016/0021-9150(91)90167-2
OpenAlex: W2001322531
Cited by: 321
References: 52
Citations by year: 2024: 1 · 2023: 3 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 6
FWCI: 21.70
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Atherosclerosis (publishedVersion)
PubMed (publishedVersion)
Funders: Northwestern University
National Institutes of Health (n01hc55016-37-0-0, n01hc55018-38-0-1, n01hc55015-48-0-1)
National Heart, Lung, and Blood Institute (N01-HC-55018, N01-HC55016, N01‐HC‐55015)
Topics: Health Sciences › Medicine › Hematology › Blood properties and coagulation
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: fibrinogen, factor VII coagulant activity, cardiovascular risk factors, cardiovascular disease, Atherosclerosis Risk in Communities Study, sex differences, racial differences, modifiable lifestyle factors, smoking, alcohol consumption, physical activity, diabetes mellitus, insulin, lipoprotein(a), LDL cholesterol, HDL cholesterol, triglycerides, menopause, white blood cell count, aging
MeSH terms: Body Constitution, Cardiovascular Diseases, Coronary Disease, Factor VII, Female, Fibrinogen, Humans, Life Style, Lipids, Male, Middle Aged, Prospective Studies, Risk Factors, Sex Factors, Smoking, Racial Groups

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks